Ambrx Biopharma, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
La Jolla, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Ambrx Biopharma, Inc. has filed 77 SEC EDGAR filings since 25 Aug 2023

SEC filing history

Showing 1-25 of 77 matching filings.

Per page
25
Current page
1
SC 13G/A File 005-94206

SC 13G/A filing

Filing date
14 Nov 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
15-12G File 000-56600

15-12G filing

Filing date
18 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 000-56600

CURRENT REPORT

Filing date
12 Mar 2024
Reporting date
08 Mar 2024
Next action
Verify source filing
EFFECT File 333-275053

EFFECT filing

Filing date
08 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-274952

S-8 POS

Filing date
08 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-271966-01

S-8 POS

Filing date
08 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-271005-01

S-8 POS

Filing date
08 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-264490-01

S-8 POS

Filing date
08 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
S-8 POS File 333-257264-01

S-8 POS

Filing date
08 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Mar 2024
Reporting date
07 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Mar 2024
Reporting date
07 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Mar 2024
Reporting date
07 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Mar 2024
Reporting date
07 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Mar 2024
Reporting date
07 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Mar 2024
Reporting date
07 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Mar 2024
Reporting date
07 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4

Filing date
07 Mar 2024
Reporting date
07 Mar 2024
SEC evidence
Open document Open filing
Next action
Verify source filing
POS AM File 333-275053

POS AM

Filing date
07 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
25-NSE/A File 000-56600

25-NSE/A filing

Filing date
07 Mar 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-56600

DEFA14A

Filing date
23 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 000-56600

DEFA14A

Filing date
22 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DFAN14A File 000-56600

DFAN14A

Filing date
15 Feb 2024
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .